6612 POSTER Disease stabilization (SD) as a surrogate...

6612 POSTER Disease stabilization (SD) as a surrogate end-point in advanced non-small-cell lung cancer (NSCLC) patients treated with erlotinib (E) or gefitinib (G)

Grossi, F., Defferrari, C., Brianti, A., Dal Bello, M.G., Loprevite, M., Catania, G., Pronzato, P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
5
Language:
english
Journal:
European Journal of Cancer Supplements
DOI:
10.1016/S1359-6349(07)71440-4
Date:
September, 2007
File:
PDF, 58 KB
english, 2007
Conversion to is in progress
Conversion to is failed